Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sexually Transmitted Diseases, Viral
Welcome,
Profile
Billing
Logout
122 Companies
161 Products
161 Products
116 Mechanisms of Action
12 Trials
2436 News
«
1
2
...
38
39
40
41
42
43
44
45
46
47
48
49
50
||||||||||
Biomarker, Trial completion:
Pharmacogenetics of Antiretroviral Drugs
(clinicaltrials.gov) - Aug 23, 2011
P4
, N=200, Completed,
Sponsor: Cliniques universitaires Saint-Luc- Universit
Not yet recruiting --> Completed
|
|||||||||
faldaprevir
(BI201335) /
Boehringer Ingelheim
Trial completion:
Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers
(clinicaltrials.gov) - Aug 22, 2011
P1
, N=14, Completed,
Sponsor: Boehringer Ingelheim
Not yet recruiting --> Completed Recruiting --> Completed
|||||
|||||
Intelence
(etravirine) /
J&J
New P4 trial, Combination therapy, IO biomarker:
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients
(clinicaltrials.gov) - Aug 21, 2011
P4
, N=220, Completed,
Sponsor: Janssen R&D Ireland
||||||||||
Selzentry
(maraviroc) /
ViiV Healthcare
,
Isentress
(raltegravir) /
Merck (MSD)
New P2 trial:
ROCnRAL: Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy
(clinicaltrials.gov) - Aug 17, 2011
P2
, N=48, Terminated,
Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
|
|||||||||
Tivicay
(dolutegravir) /
ViiV Healthcare
New P1 trial:
Drug Interaction Study Between Dolutegravir and Prednisone
(clinicaltrials.gov) - Aug 17, 2011
P1
, N=12, Completed,
Sponsor: ViiV Healthcare
||
||||||||
Enrollment closed:
Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
(clinicaltrials.gov) - Aug 16, 2011
P=N/A
, N=120, Active, not recruiting,
Sponsor: University Hospitals of Cleveland
Recruiting --> Completed Recruiting --> Active, not recruiting
||||||||||
Trial suspension:
MRSA-2: Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection
(clinicaltrials.gov) - Aug 14, 2011
P=N/A
, N=60, Suspended,
Sponsor: Uniformed Services University of the Health Sciences
Recruiting --> Active, not recruiting Recruiting --> Suspended
||||||||||
New P4 trial:
PrOMPT: Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment
(clinicaltrials.gov) - Aug 14, 2011
P4
, N=44, Terminated,
Sponsor: Prof JMA Lange
|
|||||||||
New P4 trial:
IDEAL-Study: Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
(clinicaltrials.gov) - Aug 14, 2011
P4
, N=210, Recruiting,
Sponsor: Universit
||||||||||
mupirocin
/
Generic mfg.
Enrollment closed:
Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
(clinicaltrials.gov) - Aug 14, 2011
P=N/A
, N=550, Active, not recruiting,
Sponsor: Uniformed Services University of the Health Sciences
Recruiting --> Suspended Recruiting --> Active, not recruiting
||||||||||
Enrollment open:
A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV
(clinicaltrials.gov) - Aug 11, 2011
P2
, N=750, Recruiting,
Sponsor: Nova Southeastern University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
||||||||||
Trial completion:
SWIM: Safe Drinking Water For Households With Infants Born to HIV-Positive Mothers Pilot Study
(clinicaltrials.gov) - Aug 11, 2011
P=N/A
, N=120, Completed,
Sponsor: London School of Hygiene and Tropical Medicine
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
||||||||||
Trial completion:
Integration of Family Planning and HIV Services in Tanzania
(clinicaltrials.gov) - Aug 9, 2011
P=N/A
, N=864, Completed,
Sponsor: FHI 360
Active, not recruiting --> Completed Recruiting --> Completed
||||||||||
Trial completion:
A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs
(clinicaltrials.gov) - Aug 8, 2011
P2
, N=746, Completed,
Sponsor: Johns Hopkins Bloomberg School of Public Health
Recruiting --> Completed Active, not recruiting --> Completed
||||||||||
Trial termination:
Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
(clinicaltrials.gov) - Aug 7, 2011
P=N/A
, N=26, Terminated,
Sponsor: Mount Sinai School of Medicine
Active, not recruiting --> Completed Recruiting --> Terminated; low enrollment
||||||||||
Enrollment change:
Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
(clinicaltrials.gov) - Aug 7, 2011
P=N/A
, N=26, Terminated,
Sponsor: Mount Sinai School of Medicine
Recruiting --> Terminated; low enrollment N=60 --> 26
|||||
|||||
New P2 trial:
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings
(clinicaltrials.gov) - Aug 7, 2011
P2
, N=270, Completed,
Sponsor: Novartis Vaccines
||||||||||
Epogen
(epoetin alfa) /
Amgen
Trial withdrawal:
Epoetin Alfa for HIV-Associated Neuropathy Trial
(clinicaltrials.gov) - Aug 7, 2011
P2
, N=0, Withdrawn,
Sponsor: Washington University School of Medicine
N=60 --> 26 Terminated --> Withdrawn
||||||||||
Trial completion:
Evaluation of 2 Interferon ? Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT
(clinicaltrials.gov) - Aug 7, 2011
P4
, N=240, Completed,
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Terminated --> Withdrawn Terminated --> Completed
||||||||||
Trial completion:
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
(clinicaltrials.gov) - Aug 7, 2011
P4
, N=54, Completed,
Sponsor: AIDS Clinical Trials Group
Terminated --> Completed Active, not recruiting --> Completed